Despite presenting with less severe initial hyperglycemia, ketonemia and acidemia, the SGLT2i group required a significantly greater amount of insulin to achieve a comparable resolution time of acidemia and ketonemia compared to the non-SGLT2i group. The gene discussed is INS; the disease is Hyperglycemia.